2.Transthoracic Needle Biopsy: How to Maximize Diagnostic Accuracy and Minimize Complications
Chaeuk CHUNG ; Yoonjoo KIM ; Dongil PARK
Tuberculosis and Respiratory Diseases 2020;83(Supple 1):S17-S24
Although transthoracic needle biopsy (TTNB) was introduced for lung biopsy about 40 years ago, it is still mainstay of pathologic diagnosis in lung cancer, because it is relatively inexpensive and can obtain tissue regardless of the tumor-bronchus relationship. With several technological advances, proceduralists can perform TTNB more safely and accurately. Utilizing ultrasound-guided biopsy for peripheral lesions in contact with the pleura and rapid onsite evaluation during the procedure are expected to make up the weakness of TTNB. However, due to the inherent limitations of the percutaneous approach, the incidence of complications such as pneumothorax or bleeding is inevitably higher than that of other lung biopsy techniques. Thorough understating of each biopsy modality and additional technique are fundamental for maximizing diagnostic accuracy and minimizing the complications.
3.Transthoracic Needle Biopsy: How to Maximize Diagnostic Accuracy and Minimize Complications
Chaeuk CHUNG ; Yoonjoo KIM ; Dongil PARK
Tuberculosis and Respiratory Diseases 2020;83(Supple 1):S17-S24
Although transthoracic needle biopsy (TTNB) was introduced for lung biopsy about 40 years ago, it is still mainstay of pathologic diagnosis in lung cancer, because it is relatively inexpensive and can obtain tissue regardless of the tumor-bronchus relationship. With several technological advances, proceduralists can perform TTNB more safely and accurately. Utilizing ultrasound-guided biopsy for peripheral lesions in contact with the pleura and rapid onsite evaluation during the procedure are expected to make up the weakness of TTNB. However, due to the inherent limitations of the percutaneous approach, the incidence of complications such as pneumothorax or bleeding is inevitably higher than that of other lung biopsy techniques. Thorough understating of each biopsy modality and additional technique are fundamental for maximizing diagnostic accuracy and minimizing the complications.
4.Advanced Bronchoscopic Diagnostic Techniques in Lung Cancer
Tuberculosis and Respiratory Diseases 2024;87(3):282-291
The increasing incidence of incidental pulmonary nodules necessitates effective biopsy techniques for accurate diagnosis and treatment planning. This paper reviews the widely used advanced bronchoscopic techniques, such as radial endobronchial ultrasound-guided transbronchial lung biopsy, electromagnetic navigation bronchoscopy, and the cutting-edge robotic-assisted bronchoscopy. In addition, the cryobiopsy technique, which can enhance diagnostic yield by combination with conventional biopsy tools, is described for application to peripheral pulmonary lesions and mediastinal lesions, respectively.
5.A Case of Hepatic Angiomyolipoma Mimicking Hepatocellular Carcinoma.
Dong Hyun SINN ; Dongil CHOI ; Moon Seok CHOI ; Cheol Keun PARK
The Korean Journal of Gastroenterology 2008;51(1):1-3
No abstract availble.
Angiomyolipoma/*diagnosis/pathology/surgery
;
Antigens, Neoplasm/immunology
;
Carcinoma, Hepatocellular/diagnosis/pathology/surgery
;
Diagnosis, Differential
;
Humans
;
Liver Neoplasms/*diagnosis/pathology/surgery
;
Male
;
Middle Aged
;
Neoplasm Proteins/immunology
;
Tomography, X-Ray Computed
6.Localized Foreign Body Granulomas of the Breast: Clinical and Mammographic Findings.
Dongil CHOI ; Boo Kyung HAN ; Yeon Hyeon CHOE ; Jeong Mi PARK ; Jung Hyun YANG ; Seok Jin NAM
Journal of the Korean Radiological Society 1998;38(6):1135-1138
PURPOSE: To evaluate the clinical and radiographic findings of localized foreign body (FB) granulomas onmammograms. MATERIALS AND METHODS: This study involved 13 patients with localized FB granulomas on mammograms;their history of mammoplasty or other plastic procedures was obtained by telephone interviews. Two radiologistsanalyzed the location and morphology of FB granulomas and the presence of associated linear densities orparenchymal distortion on mammograms. Four patients underwent ultrasonography. RESULTS: No patient had a historyof mammoplasty. All 13, however, had a history of plastic procedure, three to 22 (average, 12) years previously,as follows : foreign materials including silicone liquid and oil such as paraffin been injected into the anteriorneck area of nine patients, the infra-auricular area of two, and the nose of two. Multiple small, high-density,flocculent nodules representing FB granulomas were distributed bilaterally in nine patients; they were noted inthe upper inner portion of 11 of 26 breasts. In eight patients, mammograms showed linear opacities suggestingfibrosis. There was no calcification or parenchymal distortion. Though in three cases, the masses were palpable.Ultrasonography revealed several anechoic nodules with posterior enhancement in subcutaneous fatty layers, and inone, 0.2cc of oil droplet had been aspirated under ultrasonographic guidance. CONCLUSION: Localized FB granulomasof the breast could be caused by the migration of FB from cervicofacial areas. Mammography showed characteristicdistribution of upper inner portions, and the findings were similar to those of mild interstitial mammoplasty.
Breast*
;
Female
;
Foreign Bodies*
;
Granuloma
;
Granuloma, Foreign-Body*
;
Humans
;
Interviews as Topic
;
Mammaplasty
;
Mammography
;
Nose
;
Paraffin
;
Plastics
;
Silicones
;
Ultrasonography
7.Epidural Granulocytic Sarcoma involving the Thoracic Spine and Sternum in Acute Myelogenous Leukemia.
Dongil KIM ; Doyeun OH ; Sunggon PARK ; Seongwook OH ; Kyeweon KWON ; Yonghee LEE ; Myungseo KANG
Korean Journal of Hematology 1999;34(2):349-352
Granulocytic sarcoma is a localized tumor composed of immature cells of the granulocytic series. Most granulocytic sarcomas occur in the course of acute leukemia and the blast crisis of chronic leukemia. Rarely, however, it may present before leukemia becomes clinically apparent. It may also occur in patients with myeloproliferative disorders. It has been reported that it occurs in 3% to 9% of patients with acute myelogenous leukemia (AML) and the incidence of granulocytic sarcoma is reported to be higher in patients with t (8;21). However, epidural granulocytic sarcoma associated with t (8;21) is very rare. In this report, we describe a patient with AML associated with t (8;21) in whom the cord compression occurred due to epidural granulocytic sarcoma. In addition, this case present infiltration of both pleura by blast cells. She was treated with local irradiation and chemotherapy successfully.
Blast Crisis
;
Drug Therapy
;
Humans
;
Incidence
;
Leukemia
;
Leukemia, Myeloid, Acute*
;
Myeloproliferative Disorders
;
Pleura
;
Sarcoma, Myeloid*
;
Spine*
;
Sternum*
8.Transthoracic needle biopsy for diagnosis of lung cancer
Journal of the Korean Medical Association 2023;66(3):160-165
Lung cancer is the most common cause of cancer deaths worldwide and accounts for approximately 2 million deaths annually. Despite advances in lung biopsy methods using bronchoscopy, a transthoracic needle biopsy continues to be used widely owing to its excellent accessibility and cost-effectiveness.Current Concepts: Various guidance methods are used during a transthoracic needle biopsy to guide the biopsy needle toward the target lesion. Commonly used modalities include conventional computed tomography, computed tomography fluoroscopy, cone beam computed tomography, and ultrasonography. Complications of a transthoracic needle biopsy include pneumothorax (20.0%), hemorrhage or hemoptysis (11.0%), delayed pneumothorax (1.4%–4.5%), air embolism (0.02%–1.8%), and tumor seeding (0.12%–0.061%).Discussion and Conclusion: Careful selection of the guidance method and needle type, based on the risk factors, the patient’s condition, and location of the lesion is important to achieve high accuracy and low complication rates during a transthoracic needle biopsy. If possible, the bronchoscopic approach should initially be attempted in high-risk groups.
9.An Experimental Study on Hepatic Ablation Using an Expandable Radio-Frequency Needle Electrode.
Dongil CHOI ; Hyo Keun LIM ; Jong Min PARK ; Bo Kyung KANG ; Ji Young WOO ; Hyun Jung JANG ; Seung Hoon KIM ; Won Jae LEE ; Cheol Keun PARK ; Jin Seok HEO
Journal of the Korean Radiological Society 1999;41(6):1127-1132
PURPOSE: The purpose of this study was to determine the factors influencing on the size of thermal lesions after ablation using an expandable radio-frequency needle electrode in porcine liver. MATERIALS AND METHODS: Ablation procedures involved the use of a monopolar radio-frequency generator and 15-G needle electrodes with four and seven retractable hooks (RITA Medical System, Mountain View, Cal.,U.S.A.). The ablation protocol in fresh porcine liver comprised of combinations of varying hook deployment, highest set temperature, and ablation time. Following ablation, the maximum diameter of all thermal lesions was measured on a longitudinal section of the specimen. Ten representive lesions were examined by an experienced pathologist. RESULTS: At 3-cm hook deployment of the needle electrode with four lateral hooks, the size of spherical thermal lesions increased substantially with increases in the highest set temperature and ablation time until 11 minutes. After 11 minutes lesion size remained similar, with a maximum diameter of 3.3 cm. At 2-cm hook deployment, sizes decreased to about 2/3 of those at 3 cm, and at 1-cm hook deployment lesions were oblong. At 3-cm hook deployment of a needle electrode with seven hooks, the size of thermal lesions increased with increasing ablation time until 14 minutes, and the maximum diameter was 4.1 cm. Microscopic examination showed a wide zone of degeneration and focal coagulation necrosis. CONCLUSION: The size of thermal lesions produced by the use of an expandable radio-frequency needle electrode were predictable, varying according to degree of hook deployment, highest set temperature, and ablation time.
Electrodes*
;
Liver
;
Necrosis
;
Needles*
10.Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
Da Hyun KANG ; Cheol-Kyu PARK ; Chaeuk CHUNG ; In-Jae OH ; Young-Chul KIM ; Dongil PARK ; Jinhyun KIM ; Gye Cheol KWON ; Insun KWON ; Pureum SUN ; Eui-Cheol SHIN ; Jeong Eun LEE
Immune Network 2020;20(3):e27-
Although various studies on predictive markers in the use of PD-1/PD-L1 inhibitors are in progress, only PD-L1 expression levels in tumor tissues are currently used. In the present study, we investigated whether baseline serum levels of IL-6 can predict the treatment response of patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1/PD-L1 inhibitors. In our cohort of 125 NSCLC patients, the objective response rate (ORR) and disease control rate (DCR) were significantly higher in those with low IL-6 (<13.1 pg/ml) than those with high IL-6 (ORR 33.9% vs. 11.1%, p=0.003; DCR 80.6% vs. 34.9%, p<0.001). The median progression-free survival was 6.3 months (95% confidence interval [CI], 3.9–8.7) in the low IL-6 group, significantly longer than in the high IL-6 group (1.9 months, 95% CI, 1.6–2.2, p<0.001). The median overall survival in the low IL-6 group was significantly longer than in the high IL-6 group (not reached vs. 7.4 months, 95% CI, 4.8–10.0). Thus, baseline serum IL-6 levels could be a potential biomarker for predicting the efficacy and survival benefit of PD-1/PD-L1 inhibitors in NSCLC.